Concepedia

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis

Vishal Gupta, Dina Brauneis, Anthony C Shelton, Karen Quillen, Shayna Sarosiek, J. Mark Sloan, Vaishali Sanchorawala

Biology of Blood and Marrow Transplantation · 2019 · 18 citations · 15 references

DOI

Concepts

References

15

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Giovanni Palladini, Angela Dispenzieri, Morie A. Gertz et al. · Journal of Clinical Oncology · 2012 · 969 citations

, , +17

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

Martha Skinner, Vaishali Sanchorawala, David C. Seldin et al. · Annals of Internal Medicine · 2004 · 615 citations

, , +14

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

Giovanni Palladini, Ute Hegenbart, Paolo Milani et al. · Blood · 2014 · 503 citations

, , +15

A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis

Giovanni Palladini, Sajitha Sachchithanantham, Paolo Milani et al. · Blood · 2015 · 451 citations · Full text

, , +8

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

María Teresa Cibeira, Vaishali Sanchorawala, David C. Seldin et al. · Blood · 2011 · 288 citations · Full text

, , +16